Oon‐Tek Ng
Impact in
-
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
- Oncology 3
- COVID-19 and healthcare impacts 2
- Inflammatory Biomarkers in Disease Prognosis 1
-
- Antibiotic Resistance in Bacteria 2
- Co-authors
- Kalisvar Marimuthu (3 shared papers)Navin Kumar Verma (1 shared paper)Diksha Jha (1 shared paper)Rajamani Lakshminarayanan (1 shared paper)Pradeep Kumar (1 shared paper)Hemant K. Gautam (1 shared paper)Shailendra Singh Gaurav (1 shared paper)Indrajit Roy (1 shared paper)
- Journals
- Journal of Nanobiotechnology (1 paper)Clinical Microbiology and Infection (1 paper)Advanced Therapeutics (1 paper)Pharmacogenetics and Genomics (1 paper)Microbial Drug Resistance (1 paper)
- Partner nations
- SingaporeChinaSouth Korea
In The Last Decade
Oon‐Tek Ng
7 papers receiving 156 citations
Peers
Comparison fields: 5 of 64
- Molecular Medicine 34
- Applied Microbiology and Biotechnology 12
- Endocrinology 9
- Microbiology 10
- Pharmacology 14
Countries citing papers authored by Oon‐Tek Ng
This map shows the geographic impact of Oon‐Tek Ng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oon‐Tek Ng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oon‐Tek Ng more than expected).
Fields of papers citing papers by Oon‐Tek Ng
This network shows the impact of papers produced by Oon‐Tek Ng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oon‐Tek Ng. The network helps show where Oon‐Tek Ng may publish in the future.
Co-authors
The 25 scholars most cited alongside Oon‐Tek Ng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 95 | |
| 2 | 2014 | 25 | |
| 3 | 2020 | 19 | |
| 4 | 2024 | 12 | |
| 5 | 2020 | 7 | |
| 6 | 2023 | 1 | |
| 7 | 2017 | 1 |
About Oon‐Tek Ng
Oon‐Tek Ng is a scholar working on Oncology, Molecular Medicine, Radiology, Nuclear Medicine and Imaging, Biomedical Engineering and Molecular Biology, having authored 7 papers that have together received 160 indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (2 papers), Antibiotic Resistance in Bacteria (2 papers), Infection Control and Ventilation (1 paper), Nanoplatforms for cancer theranostics (1 paper), Graphene and Nanomaterials Applications (1 paper), Bacterial biofilms and quorum sensing (1 paper), Inflammatory Biomarkers in Disease Prognosis (1 paper) and Pneumonia and Respiratory Infections (1 paper). The work is most often cited by research in Molecular Medicine (34 citations), Applied Microbiology and Biotechnology (12 citations), Endocrinology (9 citations), Microbiology (10 citations) and Pharmacology (14 citations). Oon‐Tek Ng has collaborated with scholars based in Singapore, China and South Korea. Frequent co-authors include Kalisvar Marimuthu, Navin Kumar Verma, Diksha Jha, Rajamani Lakshminarayanan, Pradeep Kumar, Hemant K. Gautam, Shailendra Singh Gaurav, Indrajit Roy, Yik-Ying Teo and Ritika Kapoor. Their work appears in journals such as Journal of Nanobiotechnology, Clinical Microbiology and Infection, Advanced Therapeutics, Pharmacogenetics and Genomics and Microbial Drug Resistance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.